Trial Details
COMPLETEDBasic Information
| Clinical ID | c1393 |
|---|---|
| Identifier | NCT01257399 |
| Trial Title | Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis in Remission |
| Interventions | DRUG: Asacol|DRUG: Mesalazine |
Participant Information
| Sponsor | Tillotts Pharma AG |
|---|---|
| City | Shanghai |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-11-10 |
|---|---|
| Primary Completion Date | 2025-01-13 |
| Completion Date | 2025-03-13 |